Answers are grounded in this paper and cite their sources.
Pseudophakic macular edema (PME) commonly responds to topical anti-inflammatory therapy, although refractory cases may require sustained corticosteroid delivery. We describe a 66-year-old male with bilateral PME who received an intravitreal dexamethasone implant (Ozurdex®) in the right eye. The treated eye showed rapid anatomical and visual improvement, while the untreated fellow eye demonstrated an unexpected parallel reduction in edema with improved visual acuity. Both eyes remained stable through 3 months with normal intraocular pressures and no complications. This case illustrates a rare contralateral response to unilateral Ozurdex therapy and suggests possible systemic or cross-ocular pharmacologic effects of sustained-release corticosteroids.
No takes yet. Share an insight, caveat, or question.
Paliwal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: